Why DGX beats the market
Up 43% in a year while the S&P 500 rose 12%.
“Our long-term outlook beyond 2025 assumes steady revenue and earnings growth.”
DGX's Quality Score fell 1 point on Tue, Nov 10, to 14. It did not trade higher than the day before.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 43% in a year while the S&P 500 rose 12%.
“Our long-term outlook beyond 2025 assumes steady revenue and earnings growth.”
| The chart | Stronger than 85% of stocks |
| Latest filing | 10-Q, Oct 23 |
Quest Diagnostics Data Breach Quanum Lsm Exposes Patient Records
A results day: the move is left out.
Tue Nov 17: Jefferies 17th Annual London Global…Investor conference · date confirmed.
1 more date ahead: the conference, for Pro members.
After its last 4 reports it closed +5.6% on average, higher 4 of 4 times.
Above Averagefor quality, not price, 5 of 14 chart checks firingWhat the Quality Score means
DGX is #4 of 18 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 4 |
Net income over four quarters: DGX $1.13B, LH $1.00B, CDNA $129M, RDNT -$22.4M.
Expected to report Tue Feb 9, before the open (in 91 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $3.1B, 10% more than a year ago; a profit of $2.78 a share, from $2.16.
DGX's results filing gives no sales by line in a table we read.
| Measure | Figure |
|---|---|
| Revenues | $12.065B to $12.105B |
Sales grew 3.2% a year over 5 years, fiscal 2020 to 2025.
Pays $3.44 a share a year.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Oct 22, 2026 | -5.2% | +1.8% | +2.8% |
| Jul 23, 2026 | +8.7% | +8.6% | +12.1% |
| Apr 21, 2026 | +3.5% | +4.5% | +0.2% |
Sales grew in five of the last seven years, to $11B in 2025. It made a profit in each of the eight years.
RSI 68.1, MACD above signal, above both averages. Not scored.
Its dividends come to 28% of its free cash flow.
| Dividend | $3.44 a share a year |
| Paid out | About $378M a year |
| Free cash flow | $1.4B |
| Record | Raised each of the last 5 years |
8 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: DGX is 0.1% of VIG, 0.1% of VYM, and 0.1% of DGRO, the most of the 24 funds Breakaway covers, by their holdings as filed for Jul 31, 2026.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
“The diagnostic information services industry remains fragmented, highly competitive and subject to new competitors.”
DGX scores 14 today, which Breakaway calls Above Average. It is #4 of 18 in Services-Medical Laboratories by Quality Score, with 5 of 14 chart checks firing. Up 43% in a year while the S&P 500 rose 12%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
DGX scores 14 today, which Breakaway calls Above Average (11 to 14). That is #4 of 18 in Services-Medical Laboratories by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind DGX's 14.
Expected to report Tue Feb 9, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. DGX closed higher after 4 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.